Form EFFECT CASI Pharmaceuticals,

January 2, 2025 6:02 AM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 31, 2024 10:00 A.M.
Form: F-3
CIK: 0001962738
Company Name: CASI Pharmaceuticals, Inc.
File Number: 333-283998


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings